Global Leukapheresis Market: Overview
Leukapheresis is one of the procedures
performed in apheresis. The demand for leukapheresis is expected to grow
significantly with the rising research and development activities in
their product portfolio. Leukapheresis is a procedure of removing white
blood cells including leukemia cells and returns the rest of the blood
cells into the bloodstream. Increasing prevalence of leukemia is likely
to accelerate the growth of leukapheresis procedure in the coming years.
Report Overview @ https://www.transparencymarketresearch.com/leukapheresis-market.html
The global leukapheresis market offers
comprehensive study on the market size and major trends. The market
research report provides historical and future price trends, end-use
demand details, shares of leading companies, and production forecasts.
In the publication, the report analyzes key regions and players during
the forecast period. Both top-down and bottom-up methods have been used
to project and authenticate the market size of leukapheresis and its
segments. The key players in this market have been identified through
primary and secondary research. Also, competitive landscape of companies
are discussed by highlighting their strategic partnerships, new product
launches, and research and development initiatives.
Global Leukapheresis Market: Key Drivers and Challenges
The global leukapheresis market is likely
to be driven by some of the major factors prevailing in the industry.
Some of these factors include rising number of blood donations, and
surging demand for leukopaks. Furthermore, the growth of leukapheresis
market is driven by rising demand for leukopaks in the development of
cell-based therapies. Also, the incidence of leukemia cancer has risen
significantly in the past few years which is estimated to drive the
leukapheresis market globally. The NIH projects that the number of
leukemia cases may reach 60,300 by the end of 2018. The rising number
of trauma cases and prevalence of diseases are estimated to encourage
the growth of leukapheresis market during the forecast period.
Furthermore, growing policies on reimbursements and increasing number of
complex surgeries are anticipated to enhance the growth of this market
from 2018 to 2024.
However, high cost involved in
leukapheresis procedures and lack of qualified doctors are expected to
hamper the growth of leukapheresis market in the next few years.
Nonetheless, rising investments by government and growing competition
among key players are expected to offer immense growth opportunities to
the market players in the coming years.
Global Leukapheresis Market: Regional Outlook
Geographically, the global market for
leukapheresis is fragmented into regions which include Europe, North
America, Asia Pacific, and Middle East and Africa. Asia Pacific followed
by Europe and North America, is estimated to dominate the market
throughput the forecast period. Rising geriatric population, increasing
research on regenerative medicine, and larger presence of biotech and
pharma companies may be responsible for the growth of this region.
Global Leukapheresis Market: Competitive Insight
Some of the major players operating in
the leukapheresis product market include STEMCELL Technologies, Terumo
BCT, Haemonetics, Fresenius, Macopharma, and Asahi Kasei Medical. Some
of the other key players existing in the leukopacs global market
incorporate HemaCare, Caltag Medsystem, ZenBio, BioIVT, Key Biologics,
Precision for Medicine, and AllCells. Companies are focusing more on
partnerships, mergers and acquisitions, and product strategies in order
to maintain their position in the market and increase customer base.
No comments:
Post a Comment